Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Assessing combined anti-platelet therapy in suspected acute myocardial infarction Aspirin has been shown to be effective in the emergency treatment of acute myocardial infarction. It irreversibly inhibits platelet cyclo-oxygenase and thereby prevents the formation of the platelet aggregating agent t...
第一著者: | Second Chinese Cardiac Study (CCS-2) Collaborative Group |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2000
|
類似資料
-
COMMIT/CCS-2 Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study
著者:: Collins, R
出版事項: (2005) -
COMMIT/CCS-2 (Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study)
著者:: Chen, Z
出版事項: (2005) -
Gender difference in prognosis after acute MI among 45,852 Chinese patients in COMMIT/CCS2
著者:: Chen, Y, 等
出版事項: (2009) -
ORAL CAPTOPRIL VERSUS PLACEBO AMONG 13634 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION - INTERIM-REPORT FROM THE CHINESE CARDIAC STUDY (CCS-1)
著者:: Liu, L, 等
出版事項: (1995) -
Social Acceptance of CCS
著者:: Atsuko TANAKA
出版事項: (2020-11-01)